MedPath

Ketamin mouthwash for Mucositus treatment

Phase 2
Conditions
Chemotherapy induced oral Mucositis.
Oral mucositis (ulcerative) due to antineoplastic therapy
K12.31
Registration Number
IRCT20201218049750N1
Lead Sponsor
Congenital pediatric Hematologic diseases
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Children above 7 years old with high grade Mucositus

Exclusion Criteria

History of psychosis,
History of seizure
History of allergy to ketamin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mucositis grading. Timepoint: 1 hour after mouthwash rinisg, After esch day of trial. Method of measurement: Mucositis grading by examination.;Pain severity. Timepoint: 1 hour after rinsing mouthwash. At the end of each day of trial. Method of measurement: Questionnaire.;Oral Tolerance. Timepoint: 1 hour after rinsing mouthwash. At the end of each day of trial. Method of measurement: Questinnaire.;Mouthwash Onset of effect. Timepoint: 1 hour after rinsing mouthwash, at the end of each day of trial. Method of measurement: Questionnaire.;Mouthwash Duration of effect. Timepoint: 1 hour after rinsing mouthwash, at the end of each day of trial. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath